A Phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer

1. Bayo-Calero, J.L.
2. Mayordomo, J.I.
3. Sánchez-Rovira, P.
4. Pérez-Carrión, R.
5. Illaramendi, J.J.
6. García-Bueno, J.M.
7. González-Flores, E.
8. Crespo, C.
9. Ramos-Vázquez, M.
10. García-Palomo, A.
11. Ruiz-Borrego, M.
12. De La Haba, J.
13. Gómez-Bernal, A.
14. Yubero-Esteban, A.